Dr. Sarah Buday, a clinical psychologist specializing in pain psychology and an Associate Professor of Anesthesiology at WashU Medicine, explains the concept of the “October Slide”—a seasonal decline in well-being affecting people with chronic illnesses.
Dr. Nahman-Averbuch is leading two studies to help predict who is at risk of developing migraine disorder, and to identify the changes in brain connectivity and hormone levels that precede the onset of migraine headaches in adolescents.
The Pain Management Center at Missouri Baptist Medical Center was designated as a Top Performer in the 2024 Professional Research Consultants (PRC) Excellence in Healthcare Awards.
The Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT), including Simon Haroutounian, PhD, MSc, and Katie Holzer, PhD, LCSW, brought together a diverse group of participants from academia, industry, funding and regulatory agencies, and people with lived experience (PWLE) of pain, to developed recommendations for advancing patient engagement in clinical pain research.
Lidocaine is mostly known as a topical pain reliever, sold over the counter in a skin cream or patch. In recent years, it’s been increasingly used intravenously to treat chronic pain.
The inaugural St. Louis Translational Pain Forum (STL-TPRF) was brought to fruition through a collaborative effort between the Washington University Pain Center, the Institute for Translational Neuroscience at Saint Louis University, and the Center for Clinical Pharmacology – a joint venture between UHSP and the Department of Anesthesiology at Washington University School of Medicine in St. Louis.
When people think of pain management, they often think of pain pills; however, there are many other treatments available. One of those options is pain psychology. Sarah K. Buday, PhD, provides valuable insight into what pain psychology is and how it can improve a patient’s pain.
Jose Moron-Concepcion, PhD, the Henry E. Mallinckrodt Professor of Anesthesiology at Washington University School of Medicine in St. Louis, has been appointed to a four-year term on the National Advisory Dental and Craniofacial Research Council. The council is an extension of the National Institute for Dental and Craniofacial Research at the National Institutes of Health (NIH).
Researchers at Washington University School of Medicine in St. Louis have received a five-year, $11.7 million grant to study human genes and nerve cells to better understand how cells transmit pain and to identify new ways to treat it.
Adding to a growing body of evidence that, for many, problems related to COVID-19 linger longer than the initial infection, researchers at Washington University School of Medicine in St. Louis have found that some people infected during the pandemic’s early months experienced symptoms of peripheral neuropathy — pain, tingling and numbness in the hands and feet — during and following their bouts with the virus.